<?xml version="1.0" encoding="utf-8"?>
			<journal>
			<title>Iranian Journal of Basic Medical Sciences</title>
			<title_fa></title_fa>
			<short_title></short_title>
			<subject>Medical Sciences</subject>
			<web_url>https://ijbms.mums.ac.ir/</web_url>
			<journal_hbi_system_id>0</journal_hbi_system_id>
			<journal_hbi_system_user></journal_hbi_system_user>
			<journal_id_issn>2008-3866</journal_id_issn>
			<journal_id_issn_online>2008-3874</journal_id_issn_online>
			<journal_id_pii></journal_id_pii>
			<journal_id_doi></journal_id_doi>
			<journal_id_iranmedex></journal_id_iranmedex>
			<journal_id_magiran></journal_id_magiran>
			<journal_id_sid></journal_id_sid>
			<journal_id_nlai></journal_id_nlai>
			<journal_id_science></journal_id_science>
			<language>en</language>
			<pubdate>
				<type>jalali</type>
				<year>2026</year>
				<month>8</month>
				<day>1</day>
			</pubdate>
			<pubdate>
				<type>gregorian</type>
				<year>2026</year>
				<month>8</month>
				<day>1</day>
			</pubdate>
			<volume>29</volume>
			<number>8</number>
			<publish_type>online</publish_type>
			<publish_edition>1</publish_edition>
			<article_type>fulltext</article_type>
			<articleset><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>An in-depth examination of bone avascular necrosis and early-stage treatment modalities utilizing regenerative medicine</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Review Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Femoral head avascular necrosis (AVN) represents a debilitating, progressive pathology characterized by ischemic osteocyte loss, impaired osseous remodeling, and subsequent subchondral fracture, frequently resulting in early osteoarthritis among younger patients. Despite an array of clinical interventions, a gold-standard therapy capable of consistently restoring vascular perfusion and structural integrity while avoiding total joint replacement remains unavailable. This review offers a rigorous and focused evaluation of regenerative medicine modalities for early-phase AVN, emphasizing tissue engineering innovations. We develop a conceptual model that links pathophysiological mechanisms (ischemia-driven necrosis) to specific therapeutic targets (angiogenesis, bone formation, and mechanical stability), and evaluate strategies such as stem cell transplantation, growth factor signaling, and advanced 3D scaffolds or hydrogels. Diverging from standard descriptive summaries, we provide a critical analysis of current field-wide challenges, including the limited translational success of animal studies and the lack of standardized clinical guidelines. We conclude that injectable hydrogel platforms, functionalized with progenitor cells or angiogenic signals, offer the most compelling minimally invasive solution, provided that issues regarding mechanical durability and sustained delivery are resolved. Advancing the field will necessitate stage-specific randomized trials and a more precise alignment between experimental models and human clinical reality.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>femoral head, Injectable hydrogel, Osteonecrosis, Regenerative medicine, Stem cell therapy, Tissue engineering</keyword>
				<start_page>1131</start_page>
				<end_page>1153</end_page>
				<web_url>https://ijbms.mums.ac.ir/article_28000.html</web_url>
			<author_list><author>
				<first_name>Noshad</first_name>
				<middle_name></middle_name>
				<last_name>Peyravian</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>n.peyravian@gmail.com</email>
				<code>123060</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran|Department of Tissue Engineering and Regenerative Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Zahra</first_name>
				<middle_name></middle_name>
				<last_name>Pezeshkian</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>zahrapezeshkian1992@gmail.com</email>
				<code>123061</code>
				<coreauthor>No</coreauthor>
				<affiliation>Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran|Department of Tissue Engineering and Regenerative Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Raziyeh</first_name>
				<middle_name></middle_name>
				<last_name>Najafloo</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>raziyeh.najafloo@gmail.com</email>
				<code>123062</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Biomedical Engineering, TeMS.C., Islamic Azad University, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Maziar</first_name>
				<middle_name></middle_name>
				<last_name>Malekzadeh Kebria</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>mazi.malekzadeh@gmail.com</email>
				<code>123063</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Tissue Engineering and Regenerative Medicine, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran|Cancer Research Center, Institute of Cancer, Avicenna Health Research Institute, Hamadan University of Medical Sciences, Hamadan, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Shayan</first_name>
				<middle_name></middle_name>
				<last_name>Amiri</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>amiri.shayan23@gmail.com</email>
				<code>123064</code>
				<coreauthor>No</coreauthor>
				<affiliation>Bone and Joint Reconstruction Research Center, Department of Orthopedics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Hamzeh</first_name>
				<middle_name></middle_name>
				<last_name>Mirshekari Jahangiri</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>mirshekari07@yahoo.com</email>
				<code>123065</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Physiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Mohamad Javad</first_name>
				<middle_name></middle_name>
				<last_name>Hadi</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>mohamadjavadhadi1@gmail.com</email>
				<code>123066</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Medical Nanotechnology, Faculty of Advanced Technology in Medicine, Iran University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Hamideh</first_name>
				<middle_name></middle_name>
				<last_name>Valizadeh</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>hamidehvalizadeh164@gmail.com</email>
				<code>123067</code>
				<coreauthor>No</coreauthor>
				<affiliation>Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran|Department of Tissue Engineering and Regenerative Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Mehdi</first_name>
				<middle_name></middle_name>
				<last_name>Moghtadaei</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>mmoghtadaei@gmail.com</email>
				<code>123068</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Tissue Engineering and Regenerative Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran|Orthopedic Department, Hazrat-Rasul Hospital, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Peiman</first_name>
				<middle_name></middle_name>
				<last_name>Brouki Milan</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>peiman.brouki@gmail.com</email>
				<code>123069</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran|Department of Tissue Engineering and Regenerative Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Musculoskeletal ultrasound-guided cellular therapy: Current applications and future directions in skeletal muscle regeneration</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Review Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Skeletal muscle exhibits robust intrinsic regeneration after acute injury, yet severe, chronic, or age-related damage commonly culminates in fibrosis, fatty infiltration, and lasting functional impairment. This review integrates the cellular and molecular biology of successful healing spanning inflammation resolution, satellite-cell activation, fibro-adipogenic progenitor regulation, angiogenesis, and extracellular-matrix remodeling with the key failure modes that cellular therapies seek to overcome. It evaluates an expanding portfolio of platforms (mesenchymal stromal cells, satellite cells, iPSC-derived myogenic progenitors, exosomes, secretome, and biomaterial scaffolds) that act primarily through paracrine, immunomodulatory, and differentiative mechanisms, while acknowledging persistent translational barriers of low engraftment, immunogenicity, and scalability. Musculoskeletal ultrasound is positioned as a pivotal enabling technology: high-frequency B-mode, Doppler, elastography, and contrast-enhanced imaging provide real-time lesion mapping, vascular targeting, injectate tracking, and non-invasive longitudinal biomarkers of perfusion and stiffness. Sonoporation further enhances cell/exosome uptake and homing. Preclinical studies consistently show 2-5-fold gains in retention and functional recovery with ultrasound-guided versus blind delivery; clinical evidence, though still early-phase, reports acceptable safety and modest signals of benefit in sarcopenia, volumetric muscle loss, and Duchenne dystrophy. The review highlights how ultrasound-guided delivery, combined with optimized cellular platforms and biomaterials, addresses key translational barriers and proposes a realistic 2025-2040 roadmap centered on standardization, AI navigation, personalized hypoimmunogenic products, synergistic combinations (cells+biomaterials+sonoporation), and adequately powered RCTs with quantitative imaging endpoints. When these milestones are achieved, ultrasound-guided cellular therapies will offer a transformative solution for conditions in which endogenous repair fails.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Cellular therapy, Exosome, Fibrosis, Hydrogel, Muscle regeneration, Musculoskeletal ultrasound, Satellite cells, Sonoporation, Ultrasound-guided delivery, Volumetric muscle loss</keyword>
				<start_page>1154</start_page>
				<end_page>1173</end_page>
				<web_url>https://ijbms.mums.ac.ir/article_27868.html</web_url>
			<author_list><author>
				<first_name>Chunfeng</first_name>
				<middle_name></middle_name>
				<last_name>Yu</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>15172955121@163.com</email>
				<code>122510</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Ultrasound Medicine, Minda Hospital of Hubei Minzu University, Enshi 445000, China|Hubei Provincial Key Laboratory of Occurrence and Intervention of Rheumatic Diseases, Minda Hospital of Hubei Minzu University, Enshi 445000, Hubei, China|Hubei Provincial Clinical Medical Research Center for Nephropathy, Minda Hospital of Hubei Minzu University, Enshi 445000, Hubei, China</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Xueqin</first_name>
				<middle_name></middle_name>
				<last_name>Li</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>shaquila2022@163.com</email>
				<code>122511</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Ultrasound Medicine, Minda Hospital of Hubei Minzu University, Enshi 445000, China|Hubei Provincial Key Laboratory of Occurrence and Intervention of Rheumatic Diseases, Minda Hospital of Hubei Minzu University, Enshi 445000, Hubei, China|Hubei Provincial Clinical Medical Research Center for Nephropathy, Minda Hospital of Hubei Minzu University, Enshi 445000, Hubei, China</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Wen</first_name>
				<middle_name></middle_name>
				<last_name>Zhao</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>m15327038318@163.com</email>
				<code>122512</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Ultrasound Medicine, Minda Hospital of Hubei Minzu University, Enshi 445000, China|Hubei Provincial Key Laboratory of Occurrence and Intervention of Rheumatic Diseases, Minda Hospital of Hubei Minzu University, Enshi 445000, Hubei, China|Hubei Provincial Clinical Medical Research Center for Nephropathy, Minda Hospital of Hubei Minzu University, Enshi 445000, Hubei, China</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Lingyan</first_name>
				<middle_name></middle_name>
				<last_name>Zhou</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>lingyan.zhou100@gmail.com</email>
				<code>122509</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Department of Ultrasound Medicine, Minda Hospital of Hubei Minzu University, Enshi 445000, China|Hubei Provincial Key Laboratory of Occurrence and Intervention of Rheumatic Diseases, Minda Hospital of Hubei Minzu University, Enshi 445000, Hubei, China|Hubei Provincial Clinical Medical Research Center for Nephropathy, Minda Hospital of Hubei Minzu University, Enshi 445000, Hubei, China</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Non-coding RNAs related to PD1/PD-L1 signaling with potential diagnostic, prognostic, and therapeutic value in the tumorigenesis of brain cancers</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Review Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Brain cancers are among the most aggressive malignancies associated with significant global morbidity and mortality. Cancer immunotherapy has emerged as a promising novel approach for the treatment of brain cancer through regulating the PD-1/PD-L1 signaling and disrupting tumor immune escape. Several targeted therapies have been developed to inhibit the PD-1/PD‑L1 route, but reduced therapeutic responses and drug resistance remain a major challenge that needs to be addressed. Notably, non-coding RNAs (ncRNAs), which include microRNAs (miRNAs), circular RNAs (circRNAs), and long non-coding RNAs (lncRNAs), exert crucial effects on cell proliferation, invasion, and immune escape in the tumor microenvironment (TME). It has been shown that ncRNAs reduce tumor formation and progression by regulating the PD-1/PD-L1 pathway and by down-regulating key transcription factors, including NF-κB, JAK, and STAT. Therefore, identifying novel regulatory ncRNAs and their associated target genes offers promising opportunities for developing therapeutic interventions against brain cancer. This review highlights recent advances in understanding the regulatory role of ncRNAs on the PD-1/ PD-L1 pathway in brain cancer tumorigenesis.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Brain neoplasms, PD-1/PD-L1, Immune evasion, Non-coding RNAs, microRNAs</keyword>
				<start_page>1174</start_page>
				<end_page>1183</end_page>
				<web_url>https://ijbms.mums.ac.ir/article_28086.html</web_url>
			<author_list><author>
				<first_name>Reihane</first_name>
				<middle_name></middle_name>
				<last_name>Behnam-Rassouli</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>behnamrasouli@um.ac.ir</email>
				<code>123446</code>
				<coreauthor>No</coreauthor>
				<affiliation>Recombinant Proteins Research Group, The Research Institute of Biotechnology, Ferdowsi University of Mashhad, Mashhad, Iran|Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Farzaneh</first_name>
				<middle_name></middle_name>
				<last_name>Entezari</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>dr.farzaneentezari@gmail.com</email>
				<code>123447</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Surgical and Diagnostic Integrated Sciences, University of Genova, Genova, Italy</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Majid</first_name>
				<middle_name></middle_name>
				<last_name>Ghorbanzadeh</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>farzadkums@gmail.com</email>
				<code>123448</code>
				<coreauthor>No</coreauthor>
				<affiliation>School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Ali</first_name>
				<middle_name></middle_name>
				<last_name>Reyhani</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>reihania4002@mums.ac.ir</email>
				<code>123449</code>
				<coreauthor>No</coreauthor>
				<affiliation>Kashmar School of Medical Sciences, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Mohammadreza</first_name>
				<middle_name></middle_name>
				<last_name>Nassiri</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>nassiryr@um.ac.ir</email>
				<code>123450</code>
				<coreauthor>No</coreauthor>
				<affiliation>Recombinant Proteins Research Group, The Research Institute of Biotechnology, Ferdowsi University of Mashhad, Mashhad, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Fereshteh</first_name>
				<middle_name></middle_name>
				<last_name>Golab</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>amirferns@yahoo.com</email>
				<code>123451</code>
				<coreauthor>No</coreauthor>
				<affiliation>Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Farzad</first_name>
				<middle_name></middle_name>
				<last_name>Rahmani</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>rahmanif@mums.ac.ir</email>
				<code>123445</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Kashmar School of Medical Sciences, Mashhad University of Medical Sciences, Mashhad, Iran|Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Development of a hybrid micelle–hydrogel system for topical delivery of doxorubicin to skin cancer cells</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Original Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Objective(s): Topical delivery of anti-neoplastic agents could circumvent many drawbacks of chemotherapy in skin cancer. This study aims to develop a hybrid Hyaluronic acid-oleic acid (HA-C18) micelle–alginate hydrogel as a topical system for doxorubicin (DOX), enhancing skin penetration, providing controlled release, and localized therapy for skin cancer.Materials and Methods: DOX-loaded micelles (DOX-PMs) were prepared from the synthesized amphiphilic substance (HA-C18) and incorporated into an alginate hydrogel. Micelles were characterized for size, drug loading, and in vitro release behavior. pH and viscosity of the hydrogel were also evaluated. Ex vivo permeation through rat skin was investigated for DOX solution, DOX in hydrogel, and DOX-PMs-hydrogel. Finally, antitumor activity and flow cytometry analysis were also performed on the B16F10 cell line.Results: Size and drug loading of micelles were about 221.4±27 nm and 4.32±0.4%, respectively. pH values, and viscosity of hydrogel were 4.51±0.02, and 3.2 Pa.s, respectively. DOX was released in a burst and sustained manner after 72 hr. Results showed that micelles markedly enhanced DOX permeation, achieving a 2.1-fold increase over free drug and a 9.2-fold increase over hydrogel. DOX micelles exhibited lower cytotoxic activity against B16F10 cells compared to free DOX, due to the slower release from the micelles. Finally, in both quantitative and qualitative flow cytometry analyses, the cellular uptake was evident, and the uptake rate was lower than that of free DOX.Conclusion: The findings indicate that a hybrid micelle–hydrogel platform enables controlled delivery of DOX, enhancing topical efficacy in skin cancer while minimizing systemic exposure in a patient-compatible manner.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Doxorubicin, Hyaluronic acid, Hydrogel, Polymeric micelle, skin cancer</keyword>
				<start_page>1184</start_page>
				<end_page>1194</end_page>
				<web_url>https://ijbms.mums.ac.ir/article_27916.html</web_url>
			<author_list><author>
				<first_name>Majid</first_name>
				<middle_name></middle_name>
				<last_name>Zia-Behbahani</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>aryogan@gmail.com</email>
				<code>122738</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Pharmaceutics, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran|Students Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Elahehnaz</first_name>
				<middle_name></middle_name>
				<last_name>Parhizkar</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>eparhizkar@sums.ac.ir</email>
				<code>122739</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Pharmaceutics, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Mahdokht</first_name>
				<middle_name>Hossein</middle_name>
				<last_name>Aghdaei</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>mahdokht.aghdaei@gmail.com</email>
				<code>122740</code>
				<coreauthor>No</coreauthor>
				<affiliation>Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Elaheh</first_name>
				<middle_name></middle_name>
				<last_name>Esfandiari</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>elahehesfandiari62@gmail.com</email>
				<code>122741</code>
				<coreauthor>No</coreauthor>
				<affiliation>Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Shohreh</first_name>
				<middle_name></middle_name>
				<last_name>Alipour</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>alipour_sh@sums.ac.ir</email>
				<code>122742</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Quality Control, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Fatemeh</first_name>
				<middle_name></middle_name>
				<last_name>Ahmadi</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>fahmadi1080@gmail.com</email>
				<code>122743</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Department of Pharmaceutics, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Ponicidin alleviates atherosclerosis by inhibiting inflammation and oxidative stress through the SIRT1 and PI3K/Akt pathway</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Original Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Objective(s): Atherosclerosis (AS) is caused by dyslipidemia, chronic inflammation, and oxidative stress. Ponicidin, a diterpenoid from Isodon species, has reported anti-inflammatory and antioxidant effects, but its role in AS remains unclear.  In this study, we evaluated the therapeutic potential and safety of ponicidin in an experimental AS model.Materials and Methods: ApoE-/- mice were fed a Western diet and treated with ponicidin (10 mg/kg/day, intraperitoneally) for 12 weeks. Hepatic and renal safety were assessed using histological and serum biochemical markers. Aortic plaque burden was quantified using hematoxylin  and eosin and Oil Red O staining. Plasma lipids, cytokines, oxidative stress markers, and antioxidant enzymes were measured using biochemical assays and ELISA. The effects on SIRT1 and PI3K/Akt/eNOS signaling were analyzed using immunohistochemistry, RT-qPCR, ELISA, and Western blotting.Results: Ponicidin showed no liver or kidney toxicity and moderately altered the body weight. Treatment significantly reduced aortic root plaque coverage and lesion area while improving plasma lipid profiles (↓TG, ↓TC, ↓LDL-C, and ↑HDL-C). Serum cytokine analysis revealed decreased TNF-α, IL-1β, IL-6, MCP-1, and TGF-β1 levels, with elevated IL-10. Oxidative stress was attenuated, as evidenced by reduced malondialdehyde and myeloperoxidase levels, increased superoxide dismutase, catalase, and glutathione levels, and restored nitric oxide levels. Mechanistically, ponicidin up-regulated SIRT1 expression and enhanced the phosphorylation of PI3K, Akt, and eNOS, suggesting improved endothelial function.Conclusion: Ponicidin protects against AS by improving lipid metabolism, reducing vascular inflammation and oxidative stress, and enhancing endothelial signaling.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Atherosclerosis, Inflammation, Oxidative stress, Ponicidin, SIRT1</keyword>
				<start_page>1195</start_page>
				<end_page>1201</end_page>
				<web_url>https://ijbms.mums.ac.ir/article_27917.html</web_url>
			<author_list><author>
				<first_name>Kang</first_name>
				<middle_name></middle_name>
				<last_name>Ye</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>1329627285@qq.com</email>
				<code>122744</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Internal Medicine-Cardiovascular, Guangming Traditional Chinese Medicine Hospital of Pudong New Area, Shanghai 201399, China</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Jing</first_name>
				<middle_name></middle_name>
				<last_name>Shi</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>20136135@qq.com</email>
				<code>122745</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Internal Medicine-Cardiovascular, Guangming Traditional Chinese Medicine Hospital of Pudong New Area, Shanghai 201321, China</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Ping</first_name>
				<middle_name></middle_name>
				<last_name>Gong</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>chengeziyu@163.com</email>
				<code>122746</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Internal Medicine-Cardiovascular, Guangming Traditional Chinese Medicine Hospital of Pudong New Area, Shanghai 201321, China</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Zhongsheng</first_name>
				<middle_name></middle_name>
				<last_name>Zhu</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>drzzs66@163.com</email>
				<code>122747</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Department of Internal Medicine-Cardiovascular, Guangming Traditional Chinese Medicine Hospital of Pudong New Area, Shanghai 201399, China</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Promising therapeutic efficacy of kolaviron against prenatal valproate-induced autism spectrum disorder</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Original Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Objective(s): Autism spectrum disorder (ASD) is a lifelong neurodevelopmental condition marked by impairments in social communication, language, and behavior. Prenatal exposure to valproic acid (VPA) contributes to its pathogenesis. kolaviron (KV), a polyphenolic extract from Garcinia kola, has potent antioxidant and anti-inflammatory properties, offering neuroprotective potential in ASD models. Our study aimed to evaluate whether KV could improve the VPA-induced autism model through targeting serotonergic system, mitochondrial dysregulation, oxidative stress, and inflammation.Materials and Methods: Pregnant Wistar rats received a single intraperitoneal dose of VPA (600 mg/kg) on gestational day 12.5 to induce autism-like features in offspring. Male pups were weaned on postnatal day (PND) 21 and randomly assigned to receive KV (50 or 100 mg/kg, oral), or saline until PND 49. Behavioral tests were finally conducted and brain tissue was collected for analysis of hippocampal oxidative stress, mitochondrial dysfunction, serotonin transporter (5-HTT), serotonin receptor 7 (5-HTR7), tumor necrosis factor α (TNF), and interleukin 6 (IL-6) levels. Immunohistochemical staining for glial fibrillary acidic protein (GFAP) was also performed to assess astrocytic reaction.Results: KV-treated VPA-exposed rats showed significant improvements in social interaction and with lower repetitive behavior. Biochemically, KV decreased malondialdehyde (MDA), IL-6 and TNFα levels, improved catalase activity and mitochondrial membrane potential (MMP), and modulated serotonergic markers (5-HTT and 5-HTR7). Histologically, KV also attenuated hippocampal GFAP immunoreactivity (IRA). Conclusion: KV showed its promising potential as a complementary therapeutic agent in ASD murine model. Further studies are still warranted to clarify its further mechanisms and clinical relevance.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Autism spectrum disorder, Hippocampus, Kolaviron, Serotonin, Valproic acid</keyword>
				<start_page>1202</start_page>
				<end_page>1210</end_page>
				<web_url>https://ijbms.mums.ac.ir/article_27936.html</web_url>
			<author_list><author>
				<first_name>Vahid</first_name>
				<middle_name></middle_name>
				<last_name>Khodashenas</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>khodashenas.v@iums.ac.ir</email>
				<code>122827</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Physiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Tourandokht</first_name>
				<middle_name></middle_name>
				<last_name>Baluchnejadmojarad</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>tmojarad@yahoo.com</email>
				<code>122826</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Department of Physiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Mitra</first_name>
				<middle_name></middle_name>
				<last_name>Farbin</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>mfarbin1374@gmail.com</email>
				<code>122828</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Physiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Ali</first_name>
				<middle_name></middle_name>
				<last_name>Khodabakhshi Korelaei</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>alikhko95@yahoo.com</email>
				<code>122829</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Physiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Soraya</first_name>
				<middle_name></middle_name>
				<last_name>Mehrabi</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>mehrabi.zhila@yahoo.com</email>
				<code>122830</code>
				<coreauthor>No</coreauthor>
				<affiliation>Cellular and Molecular Research Center, Iran university of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Mehrdad</first_name>
				<middle_name></middle_name>
				<last_name>Roghani</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>mehjour@yahoo.com</email>
				<code>122831</code>
				<coreauthor>No</coreauthor>
				<affiliation>Neurophysiology Research Center, Shahed University, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Radiotherapy-associated changes in the miR-124/SP1 axis in a rat glioma model</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Original Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Objective(s): Glioma is an aggressive brain tumor that frequently involves microRNA dysregulation. Rno-miR-124-3p is a brain-enriched miRNA involved in gene regulation, with Specificity Protein 1 (SP1) as its validated target. Radiotherapy remains a cornerstone of glioma treatment; however, its molecular effects on miRNA-transcription factor axes are not fully understood. We hypothesized that radiotherapy up-regulates Rno-miR-124-3p, thereby down-regulating SP1. Accordingly, this study evaluated their expression following radiotherapy in a rat glioma model.Materials and Methods: C6 glioma cells were cultured, and an effective radiation dose was determined using an MTT assay. Sixty male Wistar rats were randomly assigned to six experimental groups: control, sham, glioma, and their corresponding radiotherapy-treated groups. Glioma was induced by stereotactic injection of C6 cells into the striatum. After radiotherapy, brain tissue was collected for histological and molecular analyses. Tumor expression of Rno-miR-124-3p and SP1 was quantified by real-time PCR. Results: In glioma-bearing rats, Rno-miR-124-3p expression was significantly down-regulated, whereas SP1 was significantly up-regulated compared with control groups (P≤0.05 and P≤0.01, respectively). After radiotherapy, an inverse pattern was observed, with increased Rno-miR-124-3p and decreased SP1 in glioma tissues (P≤0.05 and P≤0.01). Histological evaluation suggested structural differences between the glioma and radiotherapy-treated glioma groups.Conclusion: Glioma development alters the Rno-miR-124-3p/SP1 regulatory axis. Radiotherapy modulates this molecular pattern, suggesting a potential role for Rno-miR-124-3p in glioma-related pathways. Further studies are needed to clarify its functional and clinical relevance.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Animal models, Gene expression regulation, Glioma, microRNAs, Radiotherapy, Rno-miR-124-3p, Sp1 transcription factor, Tumor cell line</keyword>
				<start_page>1211</start_page>
				<end_page>1217</end_page>
				<web_url>https://ijbms.mums.ac.ir/article_28038.html</web_url>
			<author_list><author>
				<first_name>Elham</first_name>
				<middle_name></middle_name>
				<last_name>Ghasemi</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>elhamqsm121@gmail.com</email>
				<code>123243</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Biotechnology and Molecular Medicine, Faculty of Medicine, Arak University of Medical Sciences, Arak, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Mehdi</first_name>
				<middle_name></middle_name>
				<last_name>Sadegh</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>m.sadegh@arakmu.ac.ir</email>
				<code>123241</code>
				<coreauthor>No</coreauthor>
				<affiliation>Departments of Physiology, Faculty of Medicine, Arak University of Medical Sciences, Arak, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Mahdieh</first_name>
				<middle_name></middle_name>
				<last_name>Mondanizadeh</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>m.mondanizadeh@arakmu.ac.ir</email>
				<code>123239</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Department of Biotechnology and Molecular Medicine, Faculty of Medicine, Arak University of Medical Sciences, Arak, Iran|Molecular and Medicine Research Center, Arak University of Medical Sciences, Arak, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Behzad</first_name>
				<middle_name></middle_name>
				<last_name>Khansarinejad</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>b_khansarinejad@yahoo.com</email>
				<code>123240</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Microbiology, Arak University of Medical Sciences, Arak, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Fatemeh</first_name>
				<middle_name></middle_name>
				<last_name>Seif</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>fseif@arakmu.ac.ir</email>
				<code>123242</code>
				<coreauthor>No</coreauthor>
				<affiliation>School of Allied Medical Sciences, Department of Radiotherapy, Arak University of Medical Sciences and Khansari Hospital, Arak, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Cordycepin ameliorates ischemia/reperfusion-induced acute kidney injury via inhibiting apoptosis and necroptosis</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Original Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Objective(s): Cordycepin (COR) is a natural bioactive compound derived from Cordyceps militaris. Relevant studies have shown that COR can alleviate kidney damage, but the underlying mechanism of its action in the treatment of acute kidney injury (AKI) remains to be further clarified.Materials and Methods: The GSE148420 dataset and GeneCards were used to identify AKI-related targets. GeneCards was used to obtain ischemia/reperfusion (I/R)-related targets. BATMAN 1.0 and GeneCards were used to identify potential drug targets of COR. Renal function, tissue damage, and molecular markers were assessed to explore the effects of COR on apoptosis and necroptosis in the treatment of AKI.Results: Network pharmacological analysis showed that AKI and COR shared 28 drug targets. Enrichment analysis showed that the targets were involved in signaling pathways, including apoptosis and necroptosis. In vitro experiments revealed that COR alleviated hypoxia/re-oxygenation(H/R)-induced HK-2 cells injury by reducing the expression of Bax and cleaved-Caspase3 while increasing the expression of Bcl-2. Necroptosis was lessened under COR treatment in vitro and in H/R-induced HK-2 cells by reducing the expression of RIPK1, RIPK3, MLKL, and p-MLKL. COR and Nec-1 (a RIPK1 inhibitor) had the same inhibitory effect, confirming the role of COR in alleviating AKI by inhibiting RIPK1-driven necroptosis. COR alleviated AKI by ameliorating renal morphology injury and pathological injury in vivo, manifested as a decrease in Scr and BUN levels, a significant reduction in the mRNA expression levels of KIM-1 and NGAL, and a decrease in p-MLKL at the immunohistochemical level.Conclusion: COR may ameliorate I/R-induced AKI by inhibiting apoptosis and RIPK1/RIPK3/p-MLKL-mediated necroptosis.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Acute kidney injury, Apoptosis, Cordycepin, Necroptosis, Receptor-Interacting, Protein Serine-Threonine Kinase 1 (RIPK1)</keyword>
				<start_page>1218</start_page>
				<end_page>1228</end_page>
				<web_url>https://ijbms.mums.ac.ir/article_27922.html</web_url>
			<author_list><author>
				<first_name>Xiuzhao</first_name>
				<middle_name></middle_name>
				<last_name>Fan</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>fxz_bioinfo@163.com</email>
				<code>122766</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Nephrology, Fifth Hospital of Shanxi Medical University, Taiyuan, Shanxi, 030012, China|Department of Nephrology, Shanxi Provincial People’s Hospital, Taiyuan, Shanxi, 030012, China|Big Data Center of Kidney Disease, Shanxi Provincial People’s Hospital, Taiyuan, Shanxi, 030012, China</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Xiutao</first_name>
				<middle_name></middle_name>
				<last_name>Han</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>1625687797@qq.com</email>
				<code>122767</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Traditional Chinese Medicine, Yan’an Baota District People’s Hospital, Yan’an, Shaanxi, 716000, China</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Zhibo</first_name>
				<middle_name></middle_name>
				<last_name>Zhao</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>zhzbdoc@163.com</email>
				<code>122768</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Nephrology, Fifth Hospital of Shanxi Medical University, Taiyuan, Shanxi, 030012, China|Department of Nephrology, Shanxi Provincial People’s Hospital, Taiyuan, Shanxi, 030012, China|Big Data Center of Kidney Disease, Shanxi Provincial People’s Hospital, Taiyuan, Shanxi, 030012, China</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Junhu</first_name>
				<middle_name></middle_name>
				<last_name>Li</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>740671651@qq.com</email>
				<code>122769</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Nephrology, Fifth Hospital of Shanxi Medical University, Taiyuan, Shanxi, 030012, China|Department of Nephrology, Shanxi Provincial People’s Hospital, Taiyuan, Shanxi, 030012, China|Big Data Center of Kidney Disease, Shanxi Provincial People’s Hospital, Taiyuan, Shanxi, 030012, China</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Shuangshuang</first_name>
				<middle_name></middle_name>
				<last_name>Tian</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>tss255@163.com</email>
				<code>122770</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Nephrology, Fifth Hospital of Shanxi Medical University, Taiyuan, Shanxi, 030012, China|Department of Nephrology, Shanxi Provincial People’s Hospital, Taiyuan, Shanxi, 030012, China|Big Data Center of Kidney Disease, Shanxi Provincial People’s Hospital, Taiyuan, Shanxi, 030012, China</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Fang</first_name>
				<middle_name></middle_name>
				<last_name>Zhang</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>756062570@qq.com</email>
				<code>122771</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Nephrology, Fifth Hospital of Shanxi Medical University, Taiyuan, Shanxi, 030012, China|Department of Nephrology, Shanxi Provincial People’s Hospital, Taiyuan, Shanxi, 030012, China|Big Data Center of Kidney Disease, Shanxi Provincial People’s Hospital, Taiyuan, Shanxi, 030012, China</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Xiaoshuang</first_name>
				<middle_name></middle_name>
				<last_name>Zhou</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>xiaoshuangzhou69@163.com</email>
				<code>122765</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Department of Nephrology, Fifth Hospital of Shanxi Medical University, Taiyuan, Shanxi, 030012, China|Department of Nephrology, Shanxi Provincial People’s Hospital, Taiyuan, Shanxi, 030012, China|Big Data Center of Kidney Disease, Shanxi Provincial People’s Hospital, Taiyuan, Shanxi, 030012, China|Shanxi Provincial Key Laboratory of Kidney Disease, Taiyuan, Shanxi, 030012, China|Medicinal Basic Research Innovation Center of Chronic Kidney Disease, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi, 030012, China</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Fabrication of a five-layer wound dressing containing chitosan-LL37 peptide for the treatment of EB wounds and deep exudate patients</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Original Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Objective(s): This study aimed to develop and evaluate a multifunctional five-layer wound dressing that meets essential requirements for effective wound healing, including exudate absorption, antimicrobial activity, moisture retention, gas exchange, and non-damaging adhesion. The specific objective was to assess the antibacterial efficacy, biocompatibility, and wound-healing performance of a dressing incorporating chitosan–LL37 nanoparticles (CS-LL37 NPs).Materials and Methods: A five-layer wound dressing was fabricated, consisting of a silicone adhesive layer, a polyurethane (PU) foam layer embedded with CS-LL37 NPs, a polypropylene diffusion layer, a cellulose-based retention layer, and a breathable, waterproof backing layer. The CS-LL37 NPs were incorporated into the PU layer, and their antibacterial activity and cytotoxicity were evaluated in vitro. The dressing’s wound-healing performance, with and without CS-LL37 NPs, was assessed in vivo in a female Wistar rat model and compared with that of a commercial dressing (Mepilex Border).Results: The developed five-layer dressing demonstrated effective exudate management, antimicrobial activity, and favorable healing conditions. In vivo results showed wound closure rates and histological outcomes comparable to those of the commercial dressing. The inclusion of CS-LL37 NPs enhanced antibacterial performance without inducing significant cytotoxicity, indicating good biocompatibility.Conclusion: The prepared five-layer wound dressing exhibited healing performance comparable to a commercially available product. The incorporation of CS-LL37 nanoparticles showed significant potential to improve treatment outcomes, particularly for exudative wounds, and may be a promising option for patients with chronic or fragile-skin conditions such as Epidermolysis Bullosa.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Antibacterial peptide, Chitosan, Epidermolysis bullosa (EB), PDMS, Wound healing</keyword>
				<start_page>1229</start_page>
				<end_page>1240</end_page>
				<web_url>https://ijbms.mums.ac.ir/article_28028.html</web_url>
			<author_list><author>
				<first_name>Morteza</first_name>
				<middle_name></middle_name>
				<last_name>Rabiei</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>mrabiei6768@gmail.com</email>
				<code>123189</code>
				<coreauthor>No</coreauthor>
				<affiliation>Nanobiotechnology Research Center, New Health Technologies Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Mehrdad</first_name>
				<middle_name></middle_name>
				<last_name>Mosazadeh Moghadam</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>mm.genetics@gmail.com</email>
				<code>123191</code>
				<coreauthor>No</coreauthor>
				<affiliation>Tissue Engineering and Regenerative Medicine Research Center, New Health Technologies Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Hossein</first_name>
				<middle_name></middle_name>
				<last_name>Derakhshankhah</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>derakhshankhah.hossein@gmail.com</email>
				<code>123190</code>
				<coreauthor>No</coreauthor>
				<affiliation>Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Ramezan Ali</first_name>
				<middle_name></middle_name>
				<last_name>Taheri</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>r.a.taheri@gmail.com</email>
				<code>123188</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Nanobiotechnology Research Center, New Health Technologies Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Investigation of neuroprotective and antiapoptotic effects of rosmarinic acid in an in vitro Alzheimer’s disease model</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Original Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Objective(s): Rosmarinic acid (RA) exhibits anti-oxidant, anti-aging, and anti-inflammatory properties. This study aimed to investigate the effects of RA on amyloid beta (Aβ), phosphorylated tau (p-tau), α-synuclein (α-syn), Abelson tyrosine kinase (Abl), and apoptotic markers in an in vitro Alzheimer’s disease (AD) model.Materials and Methods: SH-SY5Y cells were differentiated into cholinergic neurons by all-trans retinoic acid (ATRA). CCK-8 assay was performed to determine the concentrations of Aβ, RA, and Aβ+RA on differentiated cells (D-cholinergic neurons). Then, control (D), D+Aβ, pretreatment (D+Aβ+RA), and D+RA groups were formed. Gene expression levels of apoptotic biomarkers were evaluated using qRT-PCR. Aβ, α-syn, Abl, p-tau, caspase-7 (CASP7), BAX, and cytochrome c (CYCS) protein levels were determined by ELISA.  Results: CCK-8 assay showed that RA (0.5–5 µM) was non-toxic to differentiated cells, and the IC₄₀ of Aβ₁₋₄₂ was 20 µM. Pretreatment with 1.5 µM RA protected cells from Aβ-induced toxicity. Gene expression analysis revealed that apoptotic markers (BAX, BLC2, CYCS, CASP3, CASP7, FAS, FADD) were significantly increased in the D+Aβ group compared to the control, whereas their levels were markedly reduced in the D+Aβ+RA group relative to the D+Aβ group. ELISA results corroborated qRT-PCR findings for CASP7, BAX, and CYCS. Additionally, RA decreased Aβ, α-syn, and p-tau protein levels, while Abl levels increased only in the D+RA group.Conclusion: RA exhibits neuroprotective and antiapoptotic effects by modulating apoptotic markers and reducing pathological proteins in an in vitro AD model.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Alzheimer&amp;rsquo, s Disease, Apoptosis, Neuroprotective agents, Rosmarinic acid, Cell line</keyword>
				<start_page>1241</start_page>
				<end_page>1248</end_page>
				<web_url>https://ijbms.mums.ac.ir/article_27950.html</web_url>
			<author_list><author>
				<first_name>Aysu</first_name>
				<middle_name></middle_name>
				<last_name>Şen</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>aysu.sen@erbakan.edu.tr</email>
				<code>122899</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Necmettin Erbakan University, Faculty of Medicine, Department of Physiology, Konya, Turkey</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Canan</first_name>
				<middle_name></middle_name>
				<last_name>Eroğlu Güneş</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>ceroglu@erbakan.edu.tr</email>
				<code>122900</code>
				<coreauthor>No</coreauthor>
				<affiliation>Necmettin Erbakan University, Faculty of Medicine, Department of Medical Biology, Konya, Turkey</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Ebru Nur</first_name>
				<middle_name></middle_name>
				<last_name>Dursun</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>endursun01@gmail.com</email>
				<code>122901</code>
				<coreauthor>No</coreauthor>
				<affiliation>Necmettin Erbakan University, Faculty of Medicine, Department of Medical Biology, Konya, Turkey</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Ercan</first_name>
				<middle_name></middle_name>
				<last_name>Kurar</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>ekurar@erbakan.edu.tr</email>
				<code>122902</code>
				<coreauthor>No</coreauthor>
				<affiliation>Necmettin Erbakan University, Faculty of Medicine, Department of Medical Biology, Konya, Turkey</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Selim</first_name>
				<middle_name></middle_name>
				<last_name>Kutlu</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>skutlu@erbakan.edu.tr</email>
				<code>122903</code>
				<coreauthor>No</coreauthor>
				<affiliation>Necmettin Erbakan University, Faculty of Medicine, Department of Physiology, Konya, Turkey</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Resveratrol mitigates diazinon-induced neurotoxicity during fetal brain development</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Original Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Objective(s): Disruption of transcriptional programs governing fetal neurogenesis represents a critical but underexplored mechanism of diazinon (DZN)-induced developmental neurotoxicity. This research examines whether resveratrol (RV) influences the expression of genes associated with neurogenesis and survival after prenatal exposure to DZN.Materials and Methods: Twenty-four pregnant Wistar rats were divided into DZN (40 mg/kg) group, RV (10 mg/kg), DZN+RV (40 mg/kg + 10 mg/kg), and Control. On day 21 of pregnancy, rats were cesarean sectioned, and the neonatal brains were examined using HPLC, GC-MS, real-time PCR, and histology techniques to assess RV’s neuroprotective effects against DZN-induced toxicity. Data were statistically analyzed using SPSS and GraphPad Prism. Results: DZN significantly reduced neuronal survival and altered gene expression in fetal brains, with lower Ptf1α, SOX2, BDNF, and BCL2 levels and higher BAX levels compared to controls. The simultaneous administration of RV partially restored these molecular changes. Histological findings indicated that RV mitigated neuronal damage associated with DZN, resulting in decreased dark neuron formation and preserved myelin integrity in the hippocampus and thalamus.Conclusion: Collectively, these findings suggest that DZN exposure correlates with changes in the molecular and structural composition of the fetal brain, and that RV may help regulate these effects.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Apoptosis, Diazinon, neurodevelopment, Neurogenesis, Neurotoxicity, Resveratrol, Transcription factors</keyword>
				<start_page>1249</start_page>
				<end_page>1258</end_page>
				<web_url>https://ijbms.mums.ac.ir/article_28095.html</web_url>
			<author_list><author>
				<first_name>Amir</first_name>
				<middle_name></middle_name>
				<last_name>Delavar</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>adelavar950@gmail.com</email>
				<code>123496</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Nasim</first_name>
				<middle_name></middle_name>
				<last_name>Alipour</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>nalipour971@gmail.com</email>
				<code>123497</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Basic Medical Sciences, MMS.C., Islamic Azad University, Mashhad, Iran|Innovative Medical Research Center, MMS.C., Islamic Azad University, Mashhad, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Javad</first_name>
				<middle_name></middle_name>
				<last_name>Bagheri</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>bagherijavadd@gmail.com</email>
				<code>123498</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Basic Medical Sciences, MMS.C., Islamic Azad University, Mashhad, Iran|Innovative Medical Research Center, MMS.C., Islamic Azad University, Mashhad, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Raheleh</first_name>
				<middle_name></middle_name>
				<last_name>Baradaran</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>baradaranraheleh@gmail.com</email>
				<code>123499</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Anatomical Sciences, Faculty of Medicine, Social Development and Health Promotion Research Center, Gonabad University of Medical Sciences, Gonabad, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Alireza</first_name>
				<middle_name></middle_name>
				<last_name>Seddigh</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>alirezaseddigh@nkums.ac.ir</email>
				<code>123500</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Advanced Technologies, School of Medicine, North Khorasan University of Medical 
Sciences, Bojnurd, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Elham</first_name>
				<middle_name></middle_name>
				<last_name>Feridouni</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>elhamferidouni@gmail.com</email>
				<code>123501</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Biology, Gonbad Kavous University, Golestan, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Yousef</first_name>
				<middle_name></middle_name>
				<last_name>Baghcheghi</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>y.baghcheghi@gmail.com</email>
				<code>123502</code>
				<coreauthor>No</coreauthor>
				<affiliation>Bio Environmental Health Hazards Research Center, Jiroft University of Medical Sciences, Jiroft, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Fatemeh</first_name>
				<middle_name></middle_name>
				<last_name>Rahimi Anbarkeh</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>rahimif2@nums.ac.ir</email>
				<code>123503</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Department of Basic Medical Sciences, Neyshabur University of Medical Sciences, Neyshabur, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Bioinformatic analysis and characterization of the Anti-CD20 scFv-Conjugated Fe₃O₄ nanoparticles for targeted therapy of CD20⁺ leukemia cells</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Original Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Objective(s): Chronic lymphocytic leukemia (CLL) is one of the common types of leukemia. Various approaches for CLL therapy have been advanced, but they have some adverse effects. Iron oxide (Fe3O4) nanoparticles are promising drug carriers due to their magnetic properties and biocompatibility. Materials and Methods: The recombinant anti-CD20 scFv was computationally modeled using the AlphaFold server. The complementarity-determining regions (CDR) of scFv were identified using the IMGT/V-Quest database. Molecular docking was performed separately between the scFv antibody and the CD20 antigen (ClusPro 2.0) and between Fe3O4 and the scFv (PyRx). Then, synthesized Fe₃O₄ nanoparticles were characterized using X-ray diffraction (XRD), field-emission scanning electron microscopy (FE-SEM), dynamic light scattering (DLS), and Fourier-transform infrared spectroscopy (FTIR). In vitro biological evaluation of the complexes was performed using the MTT assay.Results: The molecular docking studies revealed favorable interactions between the recombinant scFv antibody and the CD20 antigen. Fe3O4 nanoparticles were included as a simplified ligand model to explore possible surface interaction patterns with the scFv molecule, suggesting no predicted interactions with CDR regions in the docking model. Physicochemical characterization confirmed the successful synthesis and desirable structural attributes of the Fe₃O₄ nanoparticles. In vitro biological evaluation of the Fe₃O₄ nanoparticle–anti-CD20 scFv complex revealed that cell death in the Raji cell line was significantly higher than in the control groups, underscoring the targeted cytotoxic efficacy. Conclusion: These findings suggest that the Fe3O4 nanoparticle complex conjugated to an anti-CD20 scFv antibody can serve as a novel strategy for CLL treatment, contributing to the development of targeted therapies for cancer.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Chronic lymphocytic leukemia (CLL), Iron oxide nanoparticles, Molecular docking, ScFv antibody</keyword>
				<start_page>1259</start_page>
				<end_page>1268</end_page>
				<web_url>https://ijbms.mums.ac.ir/article_28039.html</web_url>
			<author_list><author>
				<first_name>Shabnam</first_name>
				<middle_name></middle_name>
				<last_name>Tavangarroosta</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>shabnamtavangar@sbmu.ac.ir</email>
				<code>123244</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Molecular Medicine, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Mojgan</first_name>
				<middle_name></middle_name>
				<last_name>Bandehpour</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>m.bandehpour@sbmu.ac.ir</email>
				<code>123245</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran|Cellular and Molecular Biology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Masoumeh</first_name>
				<middle_name></middle_name>
				<last_name>Rajabibazl</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>rajabibazl_m@yahoo.com</email>
				<code>123246</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Department of Clinical Biochemistry, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Farhood</first_name>
				<middle_name></middle_name>
				<last_name>Najafi</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>fnajafi@icrc.ac.ir</email>
				<code>123247</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Environmental Research, Institute for Color Science and Technology, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Sepideh</first_name>
				<middle_name></middle_name>
				<last_name>Ghani</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>s.ghani@sbmu.ac.ir</email>
				<code>123248</code>
				<coreauthor>No</coreauthor>
				<affiliation>Cellular and Molecular Biology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Mahmoud</first_name>
				<middle_name></middle_name>
				<last_name>Hassani</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>mahmoud.hassani@yahoo.com</email>
				<code>123249</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Molecular Medicine, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Bahram</first_name>
				<middle_name></middle_name>
				<last_name>Kazemi</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>bahram_14@yahoo.com</email>
				<code>123250</code>
				<coreauthor>No</coreauthor>
				<affiliation>Cellular and Molecular Biology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Rosemary inhalation improves the behavior and cognition of vascular cognitive impairment rats by regulating SIRT1/mTOR pathway-mediated cell apoptosis and autophagy</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Original Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Objective(s): Vascular cognitive impairment (VCI) is a major cause of behavioral and cognitive abnormalities and dementia, but there are currently no specific drugs for VCI. Rosemary oil has been found to have a role in cognitive function. This study aims to evaluate whether inhalation of rosemary can improve learning and memory in VCI rats by regulating neuronal apoptosis and autophagy.Materials and Methods: Male SD rats were used to establish a VCI rat model by bilateral common carotid artery ligation. The rats were intervened with rosemary essential oil inhalation and EX527 injection. Cognitive function was evaluated by the Morris water maze test two weeks after the operation. The pathological changes of hippocampal tissue (HE, Nissl, TEM, TUNEL) and protein expression (WB) were analyzed.Results: Compared with the sham group, the VCI group exhibited cognitive deficits, neuronal loss, mitochondrial damage, and increased neuronal apoptosis (P&lt;0.001). The levels of caspase-3, LC3B, and p-mTOR/mTOR in the hippocampal tissue were significantly elevated (P&lt;0.0001, P&lt;0.01, P&lt;0.01), while the protein level of SIRT1 was significantly reduced (P&lt;0.01). Compared with the VCI group, the rosemary group showed improved cognitive ability, ameliorated neuronal damage, and reduced neuronal apoptosis (P&lt;0.05). The levels of caspase-3, LC3B, and p-mTOR/mTOR were decreased (P&lt;0.0001, P&lt;0.01, P&lt;0.05), while the level of SIRT1 was increased (P&lt;0.05). However, intervention with EX527 attenuated this protective effect.Conclusion: Rosemary inhalation can improve behavior and cognition in VCI rats by regulating SIRT1/mTOR pathway-mediated cell apoptosis and autophagy.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Rosemary oil, Cognitive impairment, SIRT1, Apoptosis, Autophagy</keyword>
				<start_page>1269</start_page>
				<end_page>1277</end_page>
				<web_url>https://ijbms.mums.ac.ir/article_27918.html</web_url>
			<author_list><author>
				<first_name>Fengfei</first_name>
				<middle_name></middle_name>
				<last_name>Shi</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>429494126@qq.com</email>
				<code>122748</code>
				<coreauthor>No</coreauthor>
				<affiliation>Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang 330006, China</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Ensi</first_name>
				<middle_name></middle_name>
				<last_name>Hong</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>2224901965@qq.com</email>
				<code>122749</code>
				<coreauthor>No</coreauthor>
				<affiliation>Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang 330006, China</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Jiewei</first_name>
				<middle_name></middle_name>
				<last_name>Bao</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>403594318@qq.com</email>
				<code>122750</code>
				<coreauthor>No</coreauthor>
				<affiliation>Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang 330006, China</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Wenguo</first_name>
				<middle_name></middle_name>
				<last_name>Ye</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>648957967@qq.com</email>
				<code>122751</code>
				<coreauthor>No</coreauthor>
				<affiliation>Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang 330006, China</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Hui</first_name>
				<middle_name></middle_name>
				<last_name>Wang</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>wanghuissy@hotmail.com</email>
				<code>122752</code>
				<coreauthor>No</coreauthor>
				<affiliation>Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang 330006, China</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Liping</first_name>
				<middle_name></middle_name>
				<last_name>Wang</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>wlp_15797694300@126.com</email>
				<code>122753</code>
				<coreauthor>No</coreauthor>
				<affiliation>Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang 330006, China</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Yanhui</first_name>
				<middle_name></middle_name>
				<last_name>Zhang</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>13576037658@163.com</email>
				<code>122754</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang 330006, China</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Allele-specific disruption of KRAS p.G12V in colorectal cancer cells using electroporated Cas9 RNPs</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Original Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Objective(s): Colorectal cancer (CRC) is a major cause of mortality, and KRAS mutations drive tumorigenesis and therapy resistance. Although CRISPR-Cas9 enables precise genome editing, intracellular delivery of Cas9 ribonucleoproteins (RNPs) remains challenging. We evaluated direct electroporation of Cas9-sgRNA RNPs targeting KRAS p.G12V in SW480 CRC cells to assess delivery efficiency, on-target editing, off-target activity, and viability effects. Materials and Methods: An sgRNA targeting KRAS p.G12V was designed computationally. Cas9-sgRNA RNPs were assembled and validated by in vitro digestion. RNPs were electroporated into SW480 cells using a square-wave electroporation protocol; pmaxGFP served as the delivery control. On-target editing and five predicted off-target loci were assessed by Sanger sequencing and TIDE analysis. Cell viability was measured by the MTT assay.Results: Electroporation resulted in high GFP expression (~97%). TIDE analysis at the KRAS locus estimated ~27% total indels. Cells treated with KRAS-targeting RNPs exhibited significantly reduced viability compared with controls (P&lt;0.05). No detectable indels were observed at the five off-target sites. While supporting feasibility, deeper sequencing and mechanistic analyses are needed to confirm specificity. Conclusion: Direct electroporation of Cas9-sgRNA RNPs enabled efficient intracellular delivery and targeted disruption in SW480 cells, reducing viability without detectable editing at selected off-target loci. This approach is practical for KRAS-targeted studies in CRC and warrants further investigation. Direct electroporation of Cas9–sgRNA RNPs enabled efficient delivery in SW480 cells, accompanied by reduced viability, with no detectable editing at selected off-target candidates by Sanger/TIDE. These findings support RNP electroporation as a practical approach for KRAS-targeted studies in CRC and justify follow-up with amplicon deep sequencing and additional cell models.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Allele-specific, Colorectal cancer, CRISPR, Electroporation, KRAS, Ribonucleoprotein complex</keyword>
				<start_page>1278</start_page>
				<end_page>1285</end_page>
				<web_url>https://ijbms.mums.ac.ir/article_28096.html</web_url>
			<author_list><author>
				<first_name>Firouzeh</first_name>
				<middle_name></middle_name>
				<last_name>Morshedzadeh</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>f.morshedzadeh@ut.ac.ir</email>
				<code>123504</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Genetics, Faculty of Basic Sciences, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Samaneh</first_name>
				<middle_name></middle_name>
				<last_name>Sharif</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>samanehsharifsh@gmail.com</email>
				<code>123505</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Medical Genetics and Molecular Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran|Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Maryam</first_name>
				<middle_name></middle_name>
				<last_name>Peymani</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>m.peymani@iau.ir</email>
				<code>123506</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Department of Genetics, Faculty of Basic Sciences, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Malihe</first_name>
				<middle_name></middle_name>
				<last_name>Lotfi</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>lotfimalihe.genetic1395@gmail.com</email>
				<code>123507</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Medical Genetics and Molecular Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Mohammad Reza</first_name>
				<middle_name></middle_name>
				<last_name>Abbaszadegan</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>m.r.abbaszadegan@gmail.com</email>
				<code>123508</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Department of Medical Genetics and Molecular Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran|Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Neuroprotective effects of ROCK inhibition on hippocampal energy metabolism in a rat model of metabolic syndrome</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Original Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Objective(s): Metabolic syndrome (MS) is associated with insulin resistance, hyperglycemia, and dyslipidemia, leading to impaired neuronal energy metabolism and hippocampal dysfunction. Rho-associated kinase (ROCK) has been implicated in metabolic and neuroinflammatory dysregulation; however, its role in MS-induced hippocampal energy imbalance remains unclear. This study aimed to determine whether pharmacological ROCK inhibition with fasudil restores hippocampal energy metabolism in a rat model of fructose-induced MS.Materials and Methods: Male Lewis rats were divided into control, MS, and MS+fasudil groups. Plasma and hippocampal metabolic parameters were assessed using biochemical assays. Activities of glycolytic enzymes, Krebs cycle enzymes, and mitochondrial respiratory chain complexes I–IV were measured. Phosphatidylinositol 3-kinase/Protein kinase B/Mechanistic target of rapamycin (PI3K/AKT/mTOR) pathway components, including phosphorylated PI3K, AKT, mTOR, Phosphatase and tensin homolog (PTEN), and Ras homolog enriched in brain (Rheb), were analyzed by Western blotting.Results: MS disrupted glucose homeostasis and significantly suppressed the activities of glycolytic, mitochondrial, and respiratory chain enzymes in the hippocampus. These changes were accompanied by reduced phosphorylation of PI3K, AKT, and mTOR, increased PTEN expression, and decreased Rheb levels, indicating impaired PI3K/AKT/mTOR signaling. Fasudil treatment normalized plasma and hippocampal glucose levels, restored enzymatic activities across major energy-producing pathways, and reactivated PI3K/AKT/mTOR signaling by reducing PTEN and restoring AKT and Rheb activity.Conclusion: These findings demonstrate that ROCK overactivation contributes to central insulin resistance and hippocampal energy dysfunction in MS. ROCK inhibition with fasudil effectively reverses these alterations, highlighting ROCK as a potential therapeutic target for preserving hippocampal metabolic function in MS.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Energy metabolism, Fasudil, Hippocampus metabolic syndrome, Neuroprotection, PI3K/Akt/mTOR, Rho-kinase (ROCK)</keyword>
				<start_page>1286</start_page>
				<end_page>1295</end_page>
				<web_url>https://ijbms.mums.ac.ir/article_27937.html</web_url>
			<author_list><author>
				<first_name>Nikoloz</first_name>
				<middle_name></middle_name>
				<last_name>Zhgenti</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>nikoloz.zhgenti@tsu.ge</email>
				<code>122832</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Department of Biology, Faculty of Exact and Natural Sciences, Iv. Javakhishvili Tbilisi State University, Tbilisi, Georgia|Faculty of Medicine, Iv. Javakhishvili Tbilisi State University, Tbilisi, Georgian</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Otar</first_name>
				<middle_name></middle_name>
				<last_name>Bibilashvili</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>otar.bibilashvili@tsu.ge</email>
				<code>122833</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Biology, Faculty of Exact and Natural Sciences, Iv. Javakhishvili Tbilisi State University, Tbilisi, Georgia</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Irina</first_name>
				<middle_name></middle_name>
				<last_name>Petriashvili</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>irina.petriashvili@tsu.ge</email>
				<code>122834</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Pharmacology, Faculty of Medicine, Iv. Javakhishvili Tbilisi State University, Tbilisi, Georgia</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Nana</first_name>
				<middle_name></middle_name>
				<last_name>Koshoridze</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>nana.koshoridze@tsu.ge</email>
				<code>122835</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Biology, Faculty of Exact and Natural Sciences, Iv. Javakhishvili Tbilisi State University, Tbilisi, Georgia</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article>
			</articleset>
			</journal>